Merck & Co., Inc.
MRK
$125.78
$0.550.44%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -140.64% | 46.09% | -251.50% | -34.55% | -19.72% |
| Total Depreciation and Amortization | 3.91% | 4.26% | -1.12% | -11.09% | 8.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.30% | -115.87% | 1,104.85% | -33.54% | 73.35% |
| Change in Net Operating Assets | 141.50% | 727.76% | -16.94% | -122.48% | -671.11% |
| Cash from Operations | -94.45% | 37.75% | -13.90% | -71.88% | -11.95% |
| Capital Expenditure | 13.93% | 19.89% | 14.53% | -2.34% | 4.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 273.96% | 99.30% | 336.54% | 86.77% | -241.61% |
| Cash from Investing | 103.03% | 65.28% | -962.49% | -101.11% | 85.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00% | 99.90% | -- | 99.92% | 99.91% |
| Issuance of Common Stock | -97.74% | -30.00% | -15.46% | 150.00% | 97.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.83% | -6.18% | -6.50% | -6.19% | -6.51% |
| Other Financing Activities | 95.59% | -128.57% | -125.00% | 21.36% | -106.06% |
| Cash from Financing | -44.47% | -57.99% | 311.48% | 33.44% | -129.84% |
| Foreign Exchange rate Adjustments | -49.18% | 61.89% | 69.90% | 258.18% | 638.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -217.80% | 93.77% | -457.68% | -768.23% | 179.51% |
